Vantage Investment Partners LLC Raises Stake in Centene Co. (NYSE:CNC)

Vantage Investment Partners LLC lifted its holdings in shares of Centene Co. (NYSE:CNC) by 17.1% during the third quarter, HoldingsChannel reports. The firm owned 683,817 shares of the company’s stock after purchasing an additional 99,904 shares during the quarter. Centene accounts for about 4.3% of Vantage Investment Partners LLC’s investment portfolio, making the stock its 4th biggest holding. Vantage Investment Partners LLC’s holdings in Centene were worth $51,478,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. EP Wealth Advisors LLC lifted its position in Centene by 1.0% in the first quarter. EP Wealth Advisors LLC now owns 13,604 shares of the company’s stock valued at $1,068,000 after purchasing an additional 133 shares during the last quarter. WR Wealth Planners LLC increased its stake in shares of Centene by 41.4% during the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after buying an additional 137 shares during the period. Whittier Trust Co. increased its stake in shares of Centene by 10.0% during the second quarter. Whittier Trust Co. now owns 1,562 shares of the company’s stock valued at $104,000 after buying an additional 142 shares during the period. Mount Yale Investment Advisors LLC increased its stake in shares of Centene by 2.1% during the third quarter. Mount Yale Investment Advisors LLC now owns 8,082 shares of the company’s stock valued at $608,000 after buying an additional 167 shares during the period. Finally, Bleakley Financial Group LLC increased its stake in shares of Centene by 2.4% during the first quarter. Bleakley Financial Group LLC now owns 7,287 shares of the company’s stock valued at $572,000 after buying an additional 173 shares during the period. 93.63% of the stock is currently owned by institutional investors.

Centene Stock Up 1.0 %

CNC stock opened at $60.75 on Tuesday. Centene Co. has a twelve month low of $59.77 and a twelve month high of $81.42. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.64. The stock has a market cap of $30.67 billion, a P/E ratio of 10.55, a PEG ratio of 0.82 and a beta of 0.49. The business’s 50-day moving average price is $69.71 and its 200-day moving average price is $71.52.

Insider Activity

In related news, CEO Sarah London acquired 4,117 shares of the stock in a transaction dated Friday, November 8th. The shares were purchased at an average cost of $60.80 per share, with a total value of $250,313.60. Following the transaction, the chief executive officer now directly owns 667,229 shares in the company, valued at approximately $40,567,523.20. This represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on CNC. Truist Financial reduced their target price on Centene from $92.00 to $89.00 and set a “buy” rating on the stock in a research note on Monday, July 15th. Deutsche Bank Aktiengesellschaft upped their price target on Centene from $82.00 to $87.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. Barclays reduced their price target on Centene from $97.00 to $91.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 29th. Sanford C. Bernstein reduced their price target on Centene from $96.00 to $88.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 30th. Finally, Robert W. Baird reduced their price target on Centene from $83.00 to $66.00 and set a “neutral” rating on the stock in a research note on Friday, October 25th. Seven analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $83.92.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.